lentiviruses Search Results


94
VMRD Inc small ruminant lentivirus antibody test kit vmrd
Small Ruminant Lentivirus Antibody Test Kit Vmrd, supplied by VMRD Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lentiviruses/Small+Ruminant+Lentivirus+Antibody+Test+Kit%2C+cELISA/pmc08875174-207-26-32
Average 94 stars, based on 1 article reviews
small ruminant lentivirus antibody test kit vmrd - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

95
PackGene Biotech lnc lv luc fh shrna
FH knockdown promotes tumor growth in an orthotopic xenograft model. A , schematic overview of the experimental workflow. GL261 cells were transduced with lentivirus expressing luciferase and FH-targeting <t>shRNA</t> or control virus. After 48 h, transduced cells were selected using puromycin (2.5 μg/ml), and then injected intracranially into C57BL/6J mice. B , representative in vivo bioluminescence images of orthotopic xenograft-bearing mice at indicated time points. n = 10 biologically independent animals. C , quantification of bioluminescence signal intensity. n = 10 biologically independent animals. D , representative H&E-stained brain sections showing xenograft tumors. The scale bar represents 1.0 mm. E , Kaplan-Meier survival analysis showing reduced survival in the lentivirus carrying FH -targeting shRNA group. F , fumarate levels were increased in tumors from the lentivirus carrying FH -targeting shRNA group. n = 3 biologically independent animals. G , FH, 2SC, TRIM17, and Ubi protein levels in orthotopic xenografts. n = 3 biologically independent animals. Protein levels were analyzed by Western blot using Actin as a loading control. Data are presented as mean ± SD. Statistical significance was determined by two-way ANOVA followed by Šidák’s post hoc test ( C ), log-rank test ( E ) and unpaired Student’s t test ( F ). ∗p < 0.05, ∗∗p < 0.01 and ∗∗∗ p < 0.001. FH, fumarate hydratase; TRIM17, tripartite motif containing 17; Ubi, ubiquitin.
Lv Luc Fh Shrna, supplied by PackGene Biotech lnc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lentiviruses/Lentivirus+shRNA+Packaging/pmc13545428-411-0-7
Average 95 stars, based on 1 article reviews
lv luc fh shrna - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

95
Cyagen Biosciences lentivirus
FH knockdown promotes tumor growth in an orthotopic xenograft model. A , schematic overview of the experimental workflow. GL261 cells were transduced with lentivirus expressing luciferase and FH-targeting <t>shRNA</t> or control virus. After 48 h, transduced cells were selected using puromycin (2.5 μg/ml), and then injected intracranially into C57BL/6J mice. B , representative in vivo bioluminescence images of orthotopic xenograft-bearing mice at indicated time points. n = 10 biologically independent animals. C , quantification of bioluminescence signal intensity. n = 10 biologically independent animals. D , representative H&E-stained brain sections showing xenograft tumors. The scale bar represents 1.0 mm. E , Kaplan-Meier survival analysis showing reduced survival in the lentivirus carrying FH -targeting shRNA group. F , fumarate levels were increased in tumors from the lentivirus carrying FH -targeting shRNA group. n = 3 biologically independent animals. G , FH, 2SC, TRIM17, and Ubi protein levels in orthotopic xenografts. n = 3 biologically independent animals. Protein levels were analyzed by Western blot using Actin as a loading control. Data are presented as mean ± SD. Statistical significance was determined by two-way ANOVA followed by Šidák’s post hoc test ( C ), log-rank test ( E ) and unpaired Student’s t test ( F ). ∗p < 0.05, ∗∗p < 0.01 and ∗∗∗ p < 0.001. FH, fumarate hydratase; TRIM17, tripartite motif containing 17; Ubi, ubiquitin.
Lentivirus, supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lentiviruses/Lentivirus/pm33382873-57-2-8
Average 95 stars, based on 1 article reviews
lentivirus - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
TransGen biotech co translvtm lentivirus precipitation solution 5
FH knockdown promotes tumor growth in an orthotopic xenograft model. A , schematic overview of the experimental workflow. GL261 cells were transduced with lentivirus expressing luciferase and FH-targeting <t>shRNA</t> or control virus. After 48 h, transduced cells were selected using puromycin (2.5 μg/ml), and then injected intracranially into C57BL/6J mice. B , representative in vivo bioluminescence images of orthotopic xenograft-bearing mice at indicated time points. n = 10 biologically independent animals. C , quantification of bioluminescence signal intensity. n = 10 biologically independent animals. D , representative H&E-stained brain sections showing xenograft tumors. The scale bar represents 1.0 mm. E , Kaplan-Meier survival analysis showing reduced survival in the lentivirus carrying FH -targeting shRNA group. F , fumarate levels were increased in tumors from the lentivirus carrying FH -targeting shRNA group. n = 3 biologically independent animals. G , FH, 2SC, TRIM17, and Ubi protein levels in orthotopic xenografts. n = 3 biologically independent animals. Protein levels were analyzed by Western blot using Actin as a loading control. Data are presented as mean ± SD. Statistical significance was determined by two-way ANOVA followed by Šidák’s post hoc test ( C ), log-rank test ( E ) and unpaired Student’s t test ( F ). ∗p < 0.05, ∗∗p < 0.01 and ∗∗∗ p < 0.001. FH, fumarate hydratase; TRIM17, tripartite motif containing 17; Ubi, ubiquitin.
Translvtm Lentivirus Precipitation Solution 5, supplied by TransGen biotech co, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lentiviruses/TransLv+Lentivirus+Precipitation+Solution/pm39682207-103-14-20
Average 94 stars, based on 1 article reviews
translvtm lentivirus precipitation solution 5 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

92
OriGene lentitran
FH knockdown promotes tumor growth in an orthotopic xenograft model. A , schematic overview of the experimental workflow. GL261 cells were transduced with lentivirus expressing luciferase and FH-targeting <t>shRNA</t> or control virus. After 48 h, transduced cells were selected using puromycin (2.5 μg/ml), and then injected intracranially into C57BL/6J mice. B , representative in vivo bioluminescence images of orthotopic xenograft-bearing mice at indicated time points. n = 10 biologically independent animals. C , quantification of bioluminescence signal intensity. n = 10 biologically independent animals. D , representative H&E-stained brain sections showing xenograft tumors. The scale bar represents 1.0 mm. E , Kaplan-Meier survival analysis showing reduced survival in the lentivirus carrying FH -targeting shRNA group. F , fumarate levels were increased in tumors from the lentivirus carrying FH -targeting shRNA group. n = 3 biologically independent animals. G , FH, 2SC, TRIM17, and Ubi protein levels in orthotopic xenografts. n = 3 biologically independent animals. Protein levels were analyzed by Western blot using Actin as a loading control. Data are presented as mean ± SD. Statistical significance was determined by two-way ANOVA followed by Šidák’s post hoc test ( C ), log-rank test ( E ) and unpaired Student’s t test ( F ). ∗p < 0.05, ∗∗p < 0.01 and ∗∗∗ p < 0.001. FH, fumarate hydratase; TRIM17, tripartite motif containing 17; Ubi, ubiquitin.
Lentitran, supplied by OriGene, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lentiviruses/LentiTran%2C+a+transfection+reagent+for+high+titer+lentivirus+production/pm38374055-225-11-12
Average 92 stars, based on 1 article reviews
lentitran - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

92
Cyagen Biosciences lentivirus packaging
FH knockdown promotes tumor growth in an orthotopic xenograft model. A , schematic overview of the experimental workflow. GL261 cells were transduced with lentivirus expressing luciferase and FH-targeting <t>shRNA</t> or control virus. After 48 h, transduced cells were selected using puromycin (2.5 μg/ml), and then injected intracranially into C57BL/6J mice. B , representative in vivo bioluminescence images of orthotopic xenograft-bearing mice at indicated time points. n = 10 biologically independent animals. C , quantification of bioluminescence signal intensity. n = 10 biologically independent animals. D , representative H&E-stained brain sections showing xenograft tumors. The scale bar represents 1.0 mm. E , Kaplan-Meier survival analysis showing reduced survival in the lentivirus carrying FH -targeting shRNA group. F , fumarate levels were increased in tumors from the lentivirus carrying FH -targeting shRNA group. n = 3 biologically independent animals. G , FH, 2SC, TRIM17, and Ubi protein levels in orthotopic xenografts. n = 3 biologically independent animals. Protein levels were analyzed by Western blot using Actin as a loading control. Data are presented as mean ± SD. Statistical significance was determined by two-way ANOVA followed by Šidák’s post hoc test ( C ), log-rank test ( E ) and unpaired Student’s t test ( F ). ∗p < 0.05, ∗∗p < 0.01 and ∗∗∗ p < 0.001. FH, fumarate hydratase; TRIM17, tripartite motif containing 17; Ubi, ubiquitin.
Lentivirus Packaging, supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lentiviruses/Lentivirus+packaging/pm32939034-112-0-14
Average 92 stars, based on 1 article reviews
lentivirus packaging - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

94
TransGen biotech co translvtm lentivirus qpcr titration kit
FH knockdown promotes tumor growth in an orthotopic xenograft model. A , schematic overview of the experimental workflow. GL261 cells were transduced with lentivirus expressing luciferase and FH-targeting <t>shRNA</t> or control virus. After 48 h, transduced cells were selected using puromycin (2.5 μg/ml), and then injected intracranially into C57BL/6J mice. B , representative in vivo bioluminescence images of orthotopic xenograft-bearing mice at indicated time points. n = 10 biologically independent animals. C , quantification of bioluminescence signal intensity. n = 10 biologically independent animals. D , representative H&E-stained brain sections showing xenograft tumors. The scale bar represents 1.0 mm. E , Kaplan-Meier survival analysis showing reduced survival in the lentivirus carrying FH -targeting shRNA group. F , fumarate levels were increased in tumors from the lentivirus carrying FH -targeting shRNA group. n = 3 biologically independent animals. G , FH, 2SC, TRIM17, and Ubi protein levels in orthotopic xenografts. n = 3 biologically independent animals. Protein levels were analyzed by Western blot using Actin as a loading control. Data are presented as mean ± SD. Statistical significance was determined by two-way ANOVA followed by Šidák’s post hoc test ( C ), log-rank test ( E ) and unpaired Student’s t test ( F ). ∗p < 0.05, ∗∗p < 0.01 and ∗∗∗ p < 0.001. FH, fumarate hydratase; TRIM17, tripartite motif containing 17; Ubi, ubiquitin.
Translvtm Lentivirus Qpcr Titration Kit, supplied by TransGen biotech co, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lentiviruses/TransLv+Lentivirus+qPCR+Titration+Kit/pm39148990-93-9-15
Average 94 stars, based on 1 article reviews
translvtm lentivirus qpcr titration kit - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
BPS Bioscience renilla luciferase lentivirus
FH knockdown promotes tumor growth in an orthotopic xenograft model. A , schematic overview of the experimental workflow. GL261 cells were transduced with lentivirus expressing luciferase and FH-targeting <t>shRNA</t> or control virus. After 48 h, transduced cells were selected using puromycin (2.5 μg/ml), and then injected intracranially into C57BL/6J mice. B , representative in vivo bioluminescence images of orthotopic xenograft-bearing mice at indicated time points. n = 10 biologically independent animals. C , quantification of bioluminescence signal intensity. n = 10 biologically independent animals. D , representative H&E-stained brain sections showing xenograft tumors. The scale bar represents 1.0 mm. E , Kaplan-Meier survival analysis showing reduced survival in the lentivirus carrying FH -targeting shRNA group. F , fumarate levels were increased in tumors from the lentivirus carrying FH -targeting shRNA group. n = 3 biologically independent animals. G , FH, 2SC, TRIM17, and Ubi protein levels in orthotopic xenografts. n = 3 biologically independent animals. Protein levels were analyzed by Western blot using Actin as a loading control. Data are presented as mean ± SD. Statistical significance was determined by two-way ANOVA followed by Šidák’s post hoc test ( C ), log-rank test ( E ) and unpaired Student’s t test ( F ). ∗p < 0.05, ∗∗p < 0.01 and ∗∗∗ p < 0.001. FH, fumarate hydratase; TRIM17, tripartite motif containing 17; Ubi, ubiquitin.
Renilla Luciferase Lentivirus, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lentiviruses/Renilla+Luciferase+(Rluc)+Lentivirus/pm41927716-232-34-38
Average 94 stars, based on 1 article reviews
renilla luciferase lentivirus - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

92
OriGene superfectin dna transfection reagent kit
FH knockdown promotes tumor growth in an orthotopic xenograft model. A , schematic overview of the experimental workflow. GL261 cells were transduced with lentivirus expressing luciferase and FH-targeting <t>shRNA</t> or control virus. After 48 h, transduced cells were selected using puromycin (2.5 μg/ml), and then injected intracranially into C57BL/6J mice. B , representative in vivo bioluminescence images of orthotopic xenograft-bearing mice at indicated time points. n = 10 biologically independent animals. C , quantification of bioluminescence signal intensity. n = 10 biologically independent animals. D , representative H&E-stained brain sections showing xenograft tumors. The scale bar represents 1.0 mm. E , Kaplan-Meier survival analysis showing reduced survival in the lentivirus carrying FH -targeting shRNA group. F , fumarate levels were increased in tumors from the lentivirus carrying FH -targeting shRNA group. n = 3 biologically independent animals. G , FH, 2SC, TRIM17, and Ubi protein levels in orthotopic xenografts. n = 3 biologically independent animals. Protein levels were analyzed by Western blot using Actin as a loading control. Data are presented as mean ± SD. Statistical significance was determined by two-way ANOVA followed by Šidák’s post hoc test ( C ), log-rank test ( E ) and unpaired Student’s t test ( F ). ∗p < 0.05, ∗∗p < 0.01 and ∗∗∗ p < 0.001. FH, fumarate hydratase; TRIM17, tripartite motif containing 17; Ubi, ubiquitin.
Superfectin Dna Transfection Reagent Kit, supplied by OriGene, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lentiviruses/LentiTran%2C+a+transfection+reagent+for+high+titer+lentivirus+production/pmc10724390-285-13-30
Average 92 stars, based on 1 article reviews
superfectin dna transfection reagent kit - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

94
Sartorius AG neuroburst orange lentivirus
FH knockdown promotes tumor growth in an orthotopic xenograft model. A , schematic overview of the experimental workflow. GL261 cells were transduced with lentivirus expressing luciferase and FH-targeting <t>shRNA</t> or control virus. After 48 h, transduced cells were selected using puromycin (2.5 μg/ml), and then injected intracranially into C57BL/6J mice. B , representative in vivo bioluminescence images of orthotopic xenograft-bearing mice at indicated time points. n = 10 biologically independent animals. C , quantification of bioluminescence signal intensity. n = 10 biologically independent animals. D , representative H&E-stained brain sections showing xenograft tumors. The scale bar represents 1.0 mm. E , Kaplan-Meier survival analysis showing reduced survival in the lentivirus carrying FH -targeting shRNA group. F , fumarate levels were increased in tumors from the lentivirus carrying FH -targeting shRNA group. n = 3 biologically independent animals. G , FH, 2SC, TRIM17, and Ubi protein levels in orthotopic xenografts. n = 3 biologically independent animals. Protein levels were analyzed by Western blot using Actin as a loading control. Data are presented as mean ± SD. Statistical significance was determined by two-way ANOVA followed by Šidák’s post hoc test ( C ), log-rank test ( E ) and unpaired Student’s t test ( F ). ∗p < 0.05, ∗∗p < 0.01 and ∗∗∗ p < 0.001. FH, fumarate hydratase; TRIM17, tripartite motif containing 17; Ubi, ubiquitin.
Neuroburst Orange Lentivirus, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lentiviruses/Incucyte+Neuroburst+Lentivirus/pm42842648-343-13-16
Average 94 stars, based on 1 article reviews
neuroburst orange lentivirus - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

98
Sartorius AG nuclight red
FH knockdown promotes tumor growth in an orthotopic xenograft model. A , schematic overview of the experimental workflow. GL261 cells were transduced with lentivirus expressing luciferase and FH-targeting <t>shRNA</t> or control virus. After 48 h, transduced cells were selected using puromycin (2.5 μg/ml), and then injected intracranially into C57BL/6J mice. B , representative in vivo bioluminescence images of orthotopic xenograft-bearing mice at indicated time points. n = 10 biologically independent animals. C , quantification of bioluminescence signal intensity. n = 10 biologically independent animals. D , representative H&E-stained brain sections showing xenograft tumors. The scale bar represents 1.0 mm. E , Kaplan-Meier survival analysis showing reduced survival in the lentivirus carrying FH -targeting shRNA group. F , fumarate levels were increased in tumors from the lentivirus carrying FH -targeting shRNA group. n = 3 biologically independent animals. G , FH, 2SC, TRIM17, and Ubi protein levels in orthotopic xenografts. n = 3 biologically independent animals. Protein levels were analyzed by Western blot using Actin as a loading control. Data are presented as mean ± SD. Statistical significance was determined by two-way ANOVA followed by Šidák’s post hoc test ( C ), log-rank test ( E ) and unpaired Student’s t test ( F ). ∗p < 0.05, ∗∗p < 0.01 and ∗∗∗ p < 0.001. FH, fumarate hydratase; TRIM17, tripartite motif containing 17; Ubi, ubiquitin.
Nuclight Red, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lentiviruses/Incucyte+Nuclight+Red+Lentivirus/pm35935988-245-7-9
Average 98 stars, based on 1 article reviews
nuclight red - by Bioz Stars, 2026-11
98/100 stars
  Buy from Supplier

93
MedChemExpress lentivirus transfection reagent
The immune landscape, transcription regulators of LMO2 in cancers. A. Distribution of LMO2 in the major lineage cell type annotation based on the single cell RNA seq database TISCH; B. Histological distribution of LMO2 in the malignant cell type annotation based on the single cell RNA seq database TISCH; C. The pan-cancer association between endothelial cell and LMO2 in TIMER2.0. The purity and infiltration level in KIRC and LIHC was shown on the right side; D. The correlation between LMO2 with endothelial cell marker PECAM-1 in various cancer types; E. The pan-cancer association between Macrophage and LMO2 in TIMER2.0; F. The pan-cancer association between Monocyte and LMO2 in TIMER2.0; G. The pan-cancer association between Cancer associated fibroblast and LMO2 in TIMER2.0; H. The pan-cancer association between Dendritic cell and LMO2 in TIMER2.0; I. Association between LMO2 and TMB (upper), Association between LMO2 and MSI (lower). Pearson correlation analysis was used to calculate the correlation between LMO2 expression and TMB or MSI. Pearson correlation, *P < 0.05, ⁎⁎ P < 0.01, ⁎⁎⁎ P < 0.001; J. Pan cancer analysis of LMO2 expression and gene mutation status in TCGA data from cBioportal; K. Pan-cancer correlation analysis of LMO2 expression and DNA methylation level in TCGA data from GSCA; l -N. Pan-cancer correlation analysis between expressions of LMO2 and m 1 A/m 5 C/m 6 A related genes. Correlation coefficient was represented with color from green to red. Spearman correlation, *P < 0.05, ⁎⁎ P < 0.01, ⁎⁎⁎ P < 0.001; O. The m 6 A modification sites prediction of LMO2 mRNA by SRAMP; P. The mRNA expression correlation between LMO2 and ZC3H13; Q. The ZC3H13 mRNA expression in HK-2, 786-O, and ACHN. R-S. The m 6 A level of LMO2 mRNA was evaluated in 786-O and ACHN cell line transfected with the indicated plasmids; T. The m6A modification sites in LMO2 mRNA were predicted with the SRAMP online tool; U. Schematic diagram of the wild-type and mutated LMO2 reporter plasmid constructions; V. Luciferase reporter assays were performed in 293T cells after <t>transfection</t> of wild-type or mutated LMO2 reporter plasmids together with ZC3H13 expression plasmid ( n = 3 for each group); W. The 293T cells were treated with Act D for the indicated times, and the mRNA levels of LMO2 were detected by using quantitative real-time RT-PCR upon ZC3H13 overexpression ( n = 3). *P < 0.05, ⁎⁎ P < 0.01, ⁎⁎⁎ P < 0.001.
Lentivirus Transfection Reagent, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lentiviruses/Lentivirus+Transfection+Reagent/pmc12166940-61-22-25
Average 93 stars, based on 1 article reviews
lentivirus transfection reagent - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

Image Search Results


FH knockdown promotes tumor growth in an orthotopic xenograft model. A , schematic overview of the experimental workflow. GL261 cells were transduced with lentivirus expressing luciferase and FH-targeting shRNA or control virus. After 48 h, transduced cells were selected using puromycin (2.5 μg/ml), and then injected intracranially into C57BL/6J mice. B , representative in vivo bioluminescence images of orthotopic xenograft-bearing mice at indicated time points. n = 10 biologically independent animals. C , quantification of bioluminescence signal intensity. n = 10 biologically independent animals. D , representative H&E-stained brain sections showing xenograft tumors. The scale bar represents 1.0 mm. E , Kaplan-Meier survival analysis showing reduced survival in the lentivirus carrying FH -targeting shRNA group. F , fumarate levels were increased in tumors from the lentivirus carrying FH -targeting shRNA group. n = 3 biologically independent animals. G , FH, 2SC, TRIM17, and Ubi protein levels in orthotopic xenografts. n = 3 biologically independent animals. Protein levels were analyzed by Western blot using Actin as a loading control. Data are presented as mean ± SD. Statistical significance was determined by two-way ANOVA followed by Šidák’s post hoc test ( C ), log-rank test ( E ) and unpaired Student’s t test ( F ). ∗p < 0.05, ∗∗p < 0.01 and ∗∗∗ p < 0.001. FH, fumarate hydratase; TRIM17, tripartite motif containing 17; Ubi, ubiquitin.

Journal: The Journal of Biological Chemistry

Article Title: Fumarate hydratase suppresses glioblastoma progression by restricting fumarate-mediated succination of TRIM17

doi: 10.1016/j.jbc.2026.113401

Figure Lengend Snippet: FH knockdown promotes tumor growth in an orthotopic xenograft model. A , schematic overview of the experimental workflow. GL261 cells were transduced with lentivirus expressing luciferase and FH-targeting shRNA or control virus. After 48 h, transduced cells were selected using puromycin (2.5 μg/ml), and then injected intracranially into C57BL/6J mice. B , representative in vivo bioluminescence images of orthotopic xenograft-bearing mice at indicated time points. n = 10 biologically independent animals. C , quantification of bioluminescence signal intensity. n = 10 biologically independent animals. D , representative H&E-stained brain sections showing xenograft tumors. The scale bar represents 1.0 mm. E , Kaplan-Meier survival analysis showing reduced survival in the lentivirus carrying FH -targeting shRNA group. F , fumarate levels were increased in tumors from the lentivirus carrying FH -targeting shRNA group. n = 3 biologically independent animals. G , FH, 2SC, TRIM17, and Ubi protein levels in orthotopic xenografts. n = 3 biologically independent animals. Protein levels were analyzed by Western blot using Actin as a loading control. Data are presented as mean ± SD. Statistical significance was determined by two-way ANOVA followed by Šidák’s post hoc test ( C ), log-rank test ( E ) and unpaired Student’s t test ( F ). ∗p < 0.05, ∗∗p < 0.01 and ∗∗∗ p < 0.001. FH, fumarate hydratase; TRIM17, tripartite motif containing 17; Ubi, ubiquitin.

Article Snippet: LV-Luc/FH shRNA and LV-Luc/FH were produced at PackGene Biotech.

Techniques: Knockdown, Xenograft Assay, Transduction, Expressing, Luciferase, shRNA, Control, Virus, Injection, In Vivo, Staining, Western Blot, Ubiquitin Proteomics

The immune landscape, transcription regulators of LMO2 in cancers. A. Distribution of LMO2 in the major lineage cell type annotation based on the single cell RNA seq database TISCH; B. Histological distribution of LMO2 in the malignant cell type annotation based on the single cell RNA seq database TISCH; C. The pan-cancer association between endothelial cell and LMO2 in TIMER2.0. The purity and infiltration level in KIRC and LIHC was shown on the right side; D. The correlation between LMO2 with endothelial cell marker PECAM-1 in various cancer types; E. The pan-cancer association between Macrophage and LMO2 in TIMER2.0; F. The pan-cancer association between Monocyte and LMO2 in TIMER2.0; G. The pan-cancer association between Cancer associated fibroblast and LMO2 in TIMER2.0; H. The pan-cancer association between Dendritic cell and LMO2 in TIMER2.0; I. Association between LMO2 and TMB (upper), Association between LMO2 and MSI (lower). Pearson correlation analysis was used to calculate the correlation between LMO2 expression and TMB or MSI. Pearson correlation, *P < 0.05, ⁎⁎ P < 0.01, ⁎⁎⁎ P < 0.001; J. Pan cancer analysis of LMO2 expression and gene mutation status in TCGA data from cBioportal; K. Pan-cancer correlation analysis of LMO2 expression and DNA methylation level in TCGA data from GSCA; l -N. Pan-cancer correlation analysis between expressions of LMO2 and m 1 A/m 5 C/m 6 A related genes. Correlation coefficient was represented with color from green to red. Spearman correlation, *P < 0.05, ⁎⁎ P < 0.01, ⁎⁎⁎ P < 0.001; O. The m 6 A modification sites prediction of LMO2 mRNA by SRAMP; P. The mRNA expression correlation between LMO2 and ZC3H13; Q. The ZC3H13 mRNA expression in HK-2, 786-O, and ACHN. R-S. The m 6 A level of LMO2 mRNA was evaluated in 786-O and ACHN cell line transfected with the indicated plasmids; T. The m6A modification sites in LMO2 mRNA were predicted with the SRAMP online tool; U. Schematic diagram of the wild-type and mutated LMO2 reporter plasmid constructions; V. Luciferase reporter assays were performed in 293T cells after transfection of wild-type or mutated LMO2 reporter plasmids together with ZC3H13 expression plasmid ( n = 3 for each group); W. The 293T cells were treated with Act D for the indicated times, and the mRNA levels of LMO2 were detected by using quantitative real-time RT-PCR upon ZC3H13 overexpression ( n = 3). *P < 0.05, ⁎⁎ P < 0.01, ⁎⁎⁎ P < 0.001.

Journal: Translational Oncology

Article Title: LMO2 confers value as a potential immunotherapy marker in pan-cancer analysis and inhibits progression of Clear Cell Renal Cell Carcinoma

doi: 10.1016/j.tranon.2025.102409

Figure Lengend Snippet: The immune landscape, transcription regulators of LMO2 in cancers. A. Distribution of LMO2 in the major lineage cell type annotation based on the single cell RNA seq database TISCH; B. Histological distribution of LMO2 in the malignant cell type annotation based on the single cell RNA seq database TISCH; C. The pan-cancer association between endothelial cell and LMO2 in TIMER2.0. The purity and infiltration level in KIRC and LIHC was shown on the right side; D. The correlation between LMO2 with endothelial cell marker PECAM-1 in various cancer types; E. The pan-cancer association between Macrophage and LMO2 in TIMER2.0; F. The pan-cancer association between Monocyte and LMO2 in TIMER2.0; G. The pan-cancer association between Cancer associated fibroblast and LMO2 in TIMER2.0; H. The pan-cancer association between Dendritic cell and LMO2 in TIMER2.0; I. Association between LMO2 and TMB (upper), Association between LMO2 and MSI (lower). Pearson correlation analysis was used to calculate the correlation between LMO2 expression and TMB or MSI. Pearson correlation, *P < 0.05, ⁎⁎ P < 0.01, ⁎⁎⁎ P < 0.001; J. Pan cancer analysis of LMO2 expression and gene mutation status in TCGA data from cBioportal; K. Pan-cancer correlation analysis of LMO2 expression and DNA methylation level in TCGA data from GSCA; l -N. Pan-cancer correlation analysis between expressions of LMO2 and m 1 A/m 5 C/m 6 A related genes. Correlation coefficient was represented with color from green to red. Spearman correlation, *P < 0.05, ⁎⁎ P < 0.01, ⁎⁎⁎ P < 0.001; O. The m 6 A modification sites prediction of LMO2 mRNA by SRAMP; P. The mRNA expression correlation between LMO2 and ZC3H13; Q. The ZC3H13 mRNA expression in HK-2, 786-O, and ACHN. R-S. The m 6 A level of LMO2 mRNA was evaluated in 786-O and ACHN cell line transfected with the indicated plasmids; T. The m6A modification sites in LMO2 mRNA were predicted with the SRAMP online tool; U. Schematic diagram of the wild-type and mutated LMO2 reporter plasmid constructions; V. Luciferase reporter assays were performed in 293T cells after transfection of wild-type or mutated LMO2 reporter plasmids together with ZC3H13 expression plasmid ( n = 3 for each group); W. The 293T cells were treated with Act D for the indicated times, and the mRNA levels of LMO2 were detected by using quantitative real-time RT-PCR upon ZC3H13 overexpression ( n = 3). *P < 0.05, ⁎⁎ P < 0.01, ⁎⁎⁎ P < 0.001.

Article Snippet: Lentiviral particles were generated in 293T cells through co-transfection with the packaging plasmids psPAX2 and pMD2.G, along with the transfer plasmid, using lentivirus transfection reagent (MCE, USA).

Techniques: Single Cell, RNA Sequencing, Marker, Expressing, Mutagenesis, DNA Methylation Assay, Modification, Transfection, Plasmid Preparation, Luciferase, Quantitative RT-PCR, Over Expression